| Product NDC: | 0069-0006 | 
| Proprietary Name: | Etomidate | 
| Non Proprietary Name: | Etomidate | 
| Active Ingredient(s): | 2 mg/mL & nbsp; Etomidate | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0069-0006 | 
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA078289 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120203 | 
| Package NDC: | 0069-0006-01 | 
| Package Description: | 10 VIAL in 1 CARTON (0069-0006-01) > 10 mL in 1 VIAL (0069-0006-02) | 
| NDC Code | 0069-0006-01 | 
| Proprietary Name | Etomidate | 
| Package Description | 10 VIAL in 1 CARTON (0069-0006-01) > 10 mL in 1 VIAL (0069-0006-02) | 
| Product NDC | 0069-0006 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Etomidate | 
| Dosage Form Name | INJECTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20120203 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Pfizer Laboratories Div Pfizer Inc. | 
| Substance Name | ETOMIDATE | 
| Strength Number | 2 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |